Emer Hanrahan

Emer Hanrahan

UNVERIFIED PROFILE

Are you Emer Hanrahan?   Register this Author

Register author
Emer Hanrahan

Emer Hanrahan

Publications by authors named "Emer Hanrahan"

Are you Emer Hanrahan?   Register this Author

16Publications

406Reads

26Profile Views

A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck.

Am J Clin Oncol 2009 Jun;32(3):274-9

Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318187dd57DOI Listing
June 2009

Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.

J Clin Oncol 2007 Nov;25(31):4952-60

Departments of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Unit 10, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/25/31/4952.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2006.08.0499
Publisher Site
http://dx.doi.org/10.1200/JCO.2006.08.0499DOI Listing
November 2007

Vascular endothelial growth factor receptor tyrosine kinase inhibitors vandetanib (ZD6474) and AZD2171 in lung cancer.

Clin Cancer Res 2007 Aug;13(15 Pt 2):s4617-22

Departments of Thoracic/Head and Neck Medical Oncology and Cancer Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0539DOI Listing
August 2007

Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature.

J Clin Oncol 2006 May;24(13):2113-22

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.02.8035DOI Listing
May 2006

Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials.

Expert Opin Pharmacother 2005 Aug;6(9):1477-91

Department of Breast Medical Oncology, Unit 1354, UT MD Anderson Cancer Center, PO Box 301439, Houston, Texas 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.6.9.1477DOI Listing
August 2005

Non-Hodgkin lymphoma: an update.

Lancet Oncol 2004 Jun;5(6):341-53

Department of Medical Oncology, St James Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(04)01490-1DOI Listing
June 2004